Vyome Holdings, Inc. (HIND)Healthcare | Biotechnology | Cambridge, United States | NasdaqCM
2.21 USD
-0.01
(-0.450%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 2.21 Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 3:51 p.m. EDT
Vyome Holdings, Inc. (HIND) is currently in a highly volatile and declining trend, with a recent price of $2.19, significantly below its 52-week low of $1.75. The stock has shown a consistent downward movement over the past 14 days, indicating weak momentum and potential short-term risks. The short-term forecasting model suggests a slight upward movement of 2.74%, but this is not enough to offset the overall bearish sentiment. The stock's fundamentals are also concerning, with a negative trailing EPS, low revenue growth, and a high price-to-sales ratio. Additionally, there are no dividends to consider, making it unsuitable for income-focused investors. Given the lack of momentum and poor fundamentals, this stock is not recommended for short-term or long-term investment at this time. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.155274 |
| MSTL | 0.156848 |
| AutoTheta | 0.174530 |
| AutoARIMA | 0.294604 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 55% |
| H-stat | 2.75 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.192 |
| Excess Kurtosis | -0.94 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.831 |
| Revenue per Share | 0.148 |
| Market Cap | 15,510,947 |
| Website | https://www.vyometx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.94203657 |
| Address1 | Harvard Square |
| Address2 | One Mifflin Place Suite 400 |
| All Time High | 138,156,000.0 |
| All Time Low | 1.75 |
| Ask | 2.85 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 17,980 |
| Average Daily Volume3 Month | 869,626 |
| Average Volume | 869,626 |
| Average Volume10Days | 17,980 |
| Bid | 1.65 |
| Bid Size | 2 |
| Book Value | 0.413 |
| City | Cambridge |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.21 |
| Current Ratio | 1.988 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.33 |
| Day Low | 2.2 |
| Debt To Equity | 0.831 |
| Display Name | Vyome |
| Earnings Timestamp End | 1,763,064,000 |
| Earnings Timestamp Start | 1,763,064,000 |
| Ebitda | -2,735,052 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -4.344 |
| Enterprise To Revenue | 37.158 |
| Enterprise Value | 11,879,830 |
| Eps Trailing Twelve Months | -4.86 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.5204 |
| Fifty Day Average Change | -0.3104 |
| Fifty Day Average Change Percent | -0.12315506 |
| Fifty Two Week Change Percent | -94.20366 |
| Fifty Two Week High | 56.4 |
| Fifty Two Week High Change | -54.190002 |
| Fifty Two Week High Change Percent | -0.9608156 |
| Fifty Two Week Low | 1.75 |
| Fifty Two Week Low Change | 0.46000004 |
| Fifty Two Week Low Change Percent | 0.26285717 |
| Fifty Two Week Range | 1.75 - 56.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,475,760,600,000 |
| Float Shares | 3,254,351 |
| Free Cashflow | 5,105,984 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 9 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.68427 |
| Gross Profits | 218,771 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.33918 |
| Held Percent Institutions | 0.015470001 |
| Implied Shares Outstanding | 7,018,528 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,755,216,000 |
| Last Split Factor | 1:4 |
| Long Business Summary | Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts. |
| Long Name | Vyome Holdings, Inc. |
| Market | us_market |
| Market Cap | 15,510,947 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_115222623 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -10,262,007 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 15,791,688 |
| Number Of Analyst Opinions | 1 |
| Open | 2.26 |
| Operating Cashflow | -3,748,853 |
| Operating Margins | -37.07351 |
| Payout Ratio | 0.0 |
| Phone | 973-832-8147 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 2.21 |
| Post Market Time | 1,776,465,880 |
| Previous Close | 2.22 |
| Price Hint | 4 |
| Price To Book | 5.35109 |
| Price To Sales Trailing12 Months | 48.515068 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.858 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00999999 |
| Regular Market Change Percent | -0.45045 |
| Regular Market Day High | 2.33 |
| Regular Market Day Low | 2.2 |
| Regular Market Day Range | 2.2 - 2.33 |
| Regular Market Open | 2.26 |
| Regular Market Previous Close | 2.22 |
| Regular Market Price | 2.21 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 21,450 |
| Return On Assets | -0.43583 |
| Revenue Growth | -0.405 |
| Revenue Per Share | 0.148 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 7,018,528 |
| Shares Percent Shares Out | 0.0226 |
| Shares Short | 158,474 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 208,107 |
| Short Name | Vyome Holdings, Inc. |
| Short Percent Of Float | 0.0352 |
| Short Ratio | 3.87 |
| Source Interval | 15 |
| State | MA |
| Symbol | HIND |
| Target High Price | 15.0 |
| Target Low Price | 15.0 |
| Target Mean Price | 15.0 |
| Target Median Price | 15.0 |
| Total Cash | 4,982,333 |
| Total Cash Per Share | 0.71 |
| Total Debt | 31,258 |
| Total Revenue | 319,714 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.86 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.51431 |
| Two Hundred Day Average Change | -3.3043098 |
| Two Hundred Day Average Change Percent | -0.59922457 |
| Type Disp | Equity |
| Volume | 21,450 |
| Website | https://www.vyometx.com |
| Zip | 2,138 |